Editor: Akin E. Balci

Lung Cancer: Clinical and Surgical Specifications

eBook: US $129 Special Offer (PDF + Printed Copy): US $232
Printed Copy: US $168
Library License: US $516
ISBN: 978-1-60805-443-5 (Print)
ISBN: 978-1-60805-442-8 (Online)
Year of Publication: 2013
DOI: 10.2174/97816080544281130101

Introduction

Lung cancer diagnosis worldwide has advanced considerably. Progress in diagnostic techniques and therapeutic methods has greatly improved life expectancy in lung cancer patients. Information on lung cancer diagnosis and treatment is therefore useful for all medical professionals especially those who work outside the realm of pulmonology or oncology. This book answers the needs of medical professionals seeking this information and includes both internal and surgical aspects of lung cancer as well as developments in molecular research on pulmonary oncology.

The e-book is divided into several sections which cover basic research on lung cancer epidemiology and carcinogenesis and continue through treatment modalities on non-resectable and advanced stage lung cancer cases (radiofrequency ablation, microwave ablation) and new diagnostic techniques (PET scan). The e-book also contains a section dedicated to surgical treatment options in lung cancer patients. Readers will be able to equip themselves with the necessary medical information for diagnosing lung cancer and treating patients requiring surgery.

Indexed in: Book Citation Index, Science Edition, EBSCO.

Preface

This book focuses on the lung cancer, which is the mostly encountered, and one of the most challenging malignant diseases of the world. Worldwide, the annual number of new cases of lung cancer is estimated at more than one million and is expected to increase to ten million in 2025. Fortunately, the political efforts to reduce the use of tobacco are getting increasing attention in many countries and the statistics are now showing the first positive results.

Over the last decade there have been several improvements and changes in the lung cancer management. Among the epidemiologic changes we see a change in the histopathologic pattern, with a relative decrease in squamous cell carcinoma and a rise in adenocarcinoma. Much research is attempting to identify biomarkers to predict a high risk for developing lung cancer. This will be important for implementing screening and prevention strategies. There is a steady improvement of the overall management of lung cancer based on an increasing use of combined modality therapy, consisting of surgery, chemotherapy, and radiotherapy applied concurrently or sequentially in early stage disease. Furthermore, new techniques are gaining ground, both within surgery and radiotherapy, and targeted medical therapy is being offered to more and more patients.

This book is not intended as a comprehensive textbook, but as a concise summary of advances in lung cancer clinical research and treatment for the clinician. The textbook brings up-to-date information about lung cancer, based on worldwide experience, for the use of the many physicians involved in this field.

All of the authors have been selected for their expertise and proven achievement in these challenging fields; I would like to sincerely thank all of them for participating with enthusiasm in this project. I hope that the different contributions will help the readers to fill in the gaps and stimulate them for future developments.

Akin Eraslan Balci
Euphrates University
School of Medicine
Department of Thoracic Surgery
Elazig
Turkey

RELATED BOOKS

.Frontiers in Clinical Drug Research - Anti-Cancer Agents.
.Head and Neck Cancer: Hallmarks of The Inflammation Ecosystem.
.Topics in Anti-Cancer Research.
.Frontiers in Clinical Drug Research - Anti-Cancer Agents.